TECHNOLOGIES

Please read on below to learn about some of our advanced technologies for key herbicide molecules such as glyphosate, glufosinate, and phenoxy acids. We welcome phyto-pharmaceutical and distribution companies with crop protection product registration capabilities to reach out to us.

 

Our innovative herbicide formulations have undergone rigorous testing for efficacy and stability and are now available for the commercialization process. For potential buyers or licensees interested in our technologies, we facilitate the technical and market evaluation process after signing agreements for confidentiality and sample transfers.

BAT®

BETTER AUXIN TECHNOLOGY®

https://snbiotech.com/wp-content/uploads/2024/02/bat-e1706859376394.jpg

BAT® formulations have higher efficacy and provide a better solution to the problem of dicamba volatilization in GM crops than those herbicides currently on the market. For all molecules in the auxin group (group: “O” / 4), they offer a less problematic (less volatile) and more effective alternative in their primary applications (other than GM crops).

BAT®

icon

RELATES TO

chemical transformation

of herbicidal active substances from the group of phenoxy acids including: dicamba, 2,4-D and MCPA, resulting in significantly lower volatility

formulation technology

for manufacturing of these novel, fully-adjuvant loaded herbicides ensuring higher efficacy and lower drift

Status:
  • ready for commercialization (licensing or sale)
The opportunity:
  • technological leadership in the auxin / phenoxy acid herbicide segment (group ”O” / 4); better option for dicamba volatility problem in GM crops and for all auxins in their traditional uses
The offer:
  • an exclusive, global license or acquisition of full rights to the unique know-how on:
    • chemical transformation of herbicidal active substances from the group of phenoxy acids (auxins) resulting in significantly lower volatility
    • formulation technology for manufacturing of these novel, fully-adjuvant loaded herbicides
IP protection:
  • licensing or acquisition based on trade secret (know-how transfer), no intention to file a patent
  • 12 years of data protection (exclusivity) for the critical component to be obtained by a licensee / acquirer under REACH and EPA
  • no infringement of any valid patents
Territory for licensing:
  • selected countries or continents, or the whole world without territorial limitations

REASON FOR BUYER /LICENSEE INTEREST

icon
  • BAT® represents the future of traditional auxin segments, boasting lower environmental impact and higher efficacy
  • BAT® can establish a worldwide dominance in the auxin sector, potentially including doublestack (RR 2 Xtend® soybeans; XtendFlex® cotton) and triple-stack (XtendFlex Soybeans, Enlist3 soybeans) genetically modified crops
  • know-how encompasses the conversion of several products from the auxin category and some from other chemical groups
  • the technology is in its early developmental stage, leading to low entry costs
  • with an integrated multifunctional adjuvant system, BAT® addresses key factors that affect the efficacy of auxin (phenoxy acid) herbicides including solubility, water hardness, retention and translocation. Furthermore, volatility and drift have also been effectively addressed.
  • based on field and lab tests, our formulation technology and derived products show promise in the following areas:
    • significantly reduced volatility compared to currently best branded products
    • higher efficacy with a minimum expected increase of 10%
    • low drift due to the built-in anti-drift system, with a possible up to 20% of herbicide not being drifted off-site

TECHNICAL BENEFITS OF THE TECHNOLOGY

icon

BGTNext®

BETTER GLYPHOSATE TECHNOLOGY NEXT®

https://snbiotech.com/wp-content/uploads/2024/02/bgtnext-e1706859396686.jpg

BGTNext® is our company’s second formulation that follows the premise of “50% is enough.” – a common denominator of all glyphosate formulations developed by SN BIOTECH TECHNOLOGIES. This means that our perfected formulations including BGTNext® have such increased efficacy that 50% less glyphosate can be used per ha without any compromise to efficacy. This formulation of glyphosate is particularly designed to interact with BAT® auxin (phenoxyacid) herbicides, when used in mixtures in transgenic (GM) crops. It additionally nullifies dicamba volatility and due to combined improved efficacy of this mixture allows for 25% reduction of dicamba usage per ha, whereas glyphosate load can be reduced by 50% – all without compromising existing efficacy.

BGTNext®

icon

REFERS TO

a fully adjuvant-loaded 180 SL formulation of glyphosate that contains a unique adjuvant system that raises efficacy to a level at which it is possible to reduce the amount of active ingredient per ha by half! Both IPA salt and potassium salt can be used.

Status:
  • ready for commercialization (licensing or sale)
The opportunity:
  • technological leadership in the glyphosate segment (WSSA Group 9, HRAC Group G); an excellent complement to the solutions developed for genetically modified crops, i.e. BAT® and BGLuT®
The offer:
  • an exclusive global license or acquisition of full rights to the unique know-how on formulation technology for manufacturing a novel, fully-adjuvant loaded glyphosate herbicide (180 SL)
IP Protection:
  • licensing or acquisition based on trade secret (know-how transfer), no intention to file a patent
  • 12 years of data protection (exclusivity) for the critical component to be obtained by a licensee / acquirer under REACH and EPA
  • no infringement of any valid patents
Territory for licensing:
  • selected countries or continents or the whole world without territorial restrictions

REASON FOR BUYER /LICENSEE INTEREST

icon
  • BGTNext creates a coherent offering with BAT® and BGLuT® for anyone interested in entering or gaining a technical and marketing advantage in the GM crop segment
  • together with our company’s complementary products mentioned above, it can permanently solve the problem of dicamba volatility and reduce the chemical footprint and residue levels in crops
  • with an integrated multifunctional adjuvant system, BGTNext® addresses key factors affecting glyphosate efficacy, including water hardness, retention and translocation limited by biotic and abiotic stress
  • the achieved efficacy level allows a 50% reduction in the rate of active ingredient per hectare, enabling the marketing claim “50% is enough”
  • when tank-mixed with the BAT® formulation, the BGTNext® formulation raises the pH of the spray by approximately 0.5 units, resulting in reduced dicamba evaporation
  • the synergy of the combined BAT® and BGTNext® formulations that results in so much increased efficacy translates into a 25% reduction in dicamba rate per acre
  • simple manufacturing method (final formulation from components)
  • no foaming

TECHNICAL BENEFITS OF THE TECHNOLOGY

icon

BGLuT®

BETTER GLUFOSINATE TECHNOLOGY®

https://snbiotech.com/wp-content/uploads/2024/02/bglut.jpg

The innovative glufosinate formulations were developed on a similar adjuvant platform as BAT® and BGTNext®. In addition to the usual glufosinate applications, they complement the herbicide portfolio in transgenic (GM) crops particularly well and, together with BAT® and BGTNext®, make it possible to reduce s.a. doses per ha while maintaining excellent efficacy. Using the same formulation technology sole L-glufosinate formulations can also be further improved.

BGLuT®

icon

REFERS TO

formulation technology for manufacturing of novel, fully-adjuvant loaded, glufosinate based herbicides performing with 10-15% higher efficacy than market standards.

Status:
  • ready for commercialization (licensing or sale)
The opportunity:
  • technological leadership in glufosinate segment (a.i. from group ”H” / 10) – in both: current herbicides (containing active L-glufosinate ammonium and the inactive D-glufosinate ammonium) and upcoming sole L-glufosinate based herbicides which are the future of the global glufosinate market
  • improved tool in glyphosate resistance strategies
  • option to reduce a total a.i. input in GM crops (double and triple stack) by 25 % as far as glufosinate is concerned (factual sustainability)
The offer:
  • exclusive, global license or transfer of full rights to know-how
IP Protection:
  • licensing or acquisition based on trade secret (know-how transfer), no intention to file a patent
  • 12 years of data protection (exclusivity) for the critical component to be obtained by a licensee / acquirer under REACH and EPA
  • no infringement of any valid patents
Territory for licensing:
  • the whole world, without territorial limitations

REASON FOR BUYER /LICENSEE INTEREST

icon
  • every 1 % of higher efficacy of glufosinate herbicides is a leap forward vs. current situation
  • BGLuT® technology enables to produce a more efficacious herbicides based on old type of a.i. incl. D and L isomers of glufosinate and in the same way a sole L-glufosinate based
  • glufosinate role (and global use) is rapidly increasing as glyphosate weed resistance increases ($750 million in 2018 with CAGR 6.16%.) *
  • BGLuT® can ensure global leadership position in the glufosinate segment including domination in double stack (glyphosate+glufosinate tolerant) and triple stack (glyphosate+ dicamba+glufosinate or glyphosate+2,4D+glufosinate tolerant – e.g.: XtendFlex Soybeans, Enlist3 soybeans) GM crops
  • low entry cost for the prospect as technology is at early stage of development
  • higher efficacy – from 10% to 15% at average (to be yet reconfirmed on large scale in field)

TECHNICAL BENEFITS OF THE TECHNOLOGY

icon

BGTNN®

BETTER GLYPHOSATE TECHNOLOGY NN®

https://snbiotech.com/wp-content/uploads/2024/02/bgtnn.jpg

BGTNN® is our company’s third formulation, which achieves the premise of “50% is enough”. This means that it has increased efficacy, allowing for a 50% reduction in glyphosate active ingredient application per hectare while maintaining traditional levels of efficacy. The goal of developing the BGTNN® formulation was to create the most technically advanced and modern crop protection glyphosate formulation, tailored to meet the needs of today’s agriculture industry.

BGTNN®

icon

REFERS TO

a strategy that aims to address all factors that affect the efficacy of glyphosate, including drift, obtaining new patent protection and associated commercialization opportunities, and securing potential licensee(s) as the global technological and price leader in the glyphosate-based herbicide segment.

The BGTNN® is a 180 GW (water soluble gel) glyphosate formulation, fully loaded with a unique multifunctional adjuvant system that increases efficacy to unprecedented level which allows for a reduction of the active ingredient per hectare by half. It is also the first glyphosate formulation in the world equipped with an effective anti-drift system.

Status:
  • the patent and the related formulation know-how are ready for commercialization through licensing or sale
The opportunity:
  • BGTNN® signifies technological leadership in the glyphosate segment (WSSA Group 9, HRAC Group G) along with tremendous marketing and pricing potential
  • twenty+ years of patent protection secures the investment in rights acquisition and product registration
The offer:
  • acquisition of the exclusive global license or full rights to the patent for the technology used in producing the world’s first glyphosate herbicide fully loaded with multicomponent adjuvant and anti-drift systems
IP Protection:
  • PCT patent pending with priority date of January 17, 2023
Territory for licensing:
  • selected countries or continents or the whole world without territorial restrictions

REASON FOR BUYER /LICENSEE INTEREST

icon
  • BGTNN® is the most advanced, high-end glyphosate formulation technology that directly meets the requirements of the EU Green Deal and other policies aimed at reducing the chemical footprint in agriculture, protecting the environment and improving food safety. The reasonable up-front costs combined with unbeatable COGs – even in relation to the cheapest 360 SL generics, followed by twenty plus years of patent protection will secure a high return on investment.

 

BGTNN® will provide a technological and profit advantage over any current product on the market!

  • multi-component and multi-functional adjuvant system leveling all factors affecting the efficacy of glyphosate
  • the achieved efficacy levels allow a 50% reduction in the dose of the active substance per hectare, in accordance with the marketing positioning: “50% is enough”
  • the anti-drift built into the formulation provides greater safety in the application of glyphosate and up to 20% more active ingredient at the application site
  • no foaming
  • humectant properties for the spray deposit
  • unrivaled manufacturing cost giving a profit advantage even in the most commoditized market situations
  • all components on EPA list – i.e., no registration risks

TECHNICAL BENEFITS OF THE TECHNOLOGY

icon
back to top